特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
917691

世界のCRISPR技術市場:2019年~2025年の予測

Global CRISPR Technology Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
世界のCRISPR技術市場:2019年~2025年の予測
出版日: 2019年10月01日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界のCRISPR技術市場について調査しており、市場機会、成長および阻害要因、用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査方法・ツール
  • 市場分析
    • セグメント別
    • 地域別

第2章 市場の概要および洞察

  • レポートの範囲
  • アナリストの洞察および現在の市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 規則・規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析
    • Thermo Fisher Scientific、Inc.
    • Merck KGaA
    • GenScript Biotech Corp.
    • Horizon Discovery Group PLC
    • CRISPR Therapeutics AG

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 市場セグメント

  • 用途別
    • 生物医学用途
    • 農業用途
    • 産業用途
  • エンドユーザー別
    • 製薬会社・バイオ医薬品会社
    • 学術研究機関

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • AstraZeneca PLC
  • BASF SE
  • Beam Therapeutics Inc.
  • Bio-Rad Laboratories, Inc.
  • Caribou Bioscience Inc.
  • Cellectics SA
  • Cibus, Ltd.
  • CRISPR Therapeutics AG
  • Danaher Corp.
  • Editas Medicine
  • GeneCopoeia inc.
  • GenScript Biotech Corp.
  • Horizon Discovery Group PLC
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Pairwise Plants
  • Precision Bioscience, Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific, Inc.
  • Transposagen Biopharmaceuticals, Inc.
  • Tropic Biosciences UK LTD.
  • Yield10 Bioscience, Inc.
図表

List of Tables

  • 1. GLOBAL CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 2. GLOBAL CRISPR FOR BIOMEDICAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL CRISPR FOR AGRICULTURAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL CRISPR FOR INDUSTRIAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 6. GLOBAL CRISPR IN PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL CRISPR IN ACADEMIC & RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 9. NORTH AMERICAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 10. NORTH AMERICAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 11. NORTH AMERICAN CRISPR MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 12. EUROPEAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 13. EUROPEAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 14. EUROPEAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
  • 15. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 16. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER 2018-2025 ($ MILLION)
  • 18. REST OF THE WORLD CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 19. REST OF THE WORLD CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL CRISPR TECHNOLOGY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 2. GLOBAL CRISPR TECHNOLOGY MARKET SHARE BY END-USER, 2018 VS 2025 (%)
  • 3. GLOBAL CRISPR TECHNOLOGY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. REST OF EUROPE CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019904

Title:
CRISPR Technology
Market Size, Share & Trends Analysis Report, By Application (Biomedical Applications, Agricultural Applications, and Industrial Applications), By End-User (Pharmaceutical & Biopharmaceutical Companies and Academic & Research Institutes), and Forecast 2019-2025.

The global CRISPR technology market is expected to witness a significant growth rate during the forecast period. CRISPR technology enables the alteration of DNA sequences and modifies the gene function. CRISPR technology can be used for various applications such as treatment of diseases, correcting gene, crop modification, bio-fuel manufacturing and many more. Industry giants are working in CRISPR technology development and are investing in the R&D of the technology. Such investments are expected to create an opportunity for the growth of the market in the near future.

The global CRISPR technology market is segmented on the basis of application and end-user. Based on the application, the market is segmented into biomedical applications, agricultural applications, and industrial applications. In fruit crops, CRISPR technology has numerous applications as it improves the important agronomic traits such as biotic and abiotic stress tolerance and fruit quality. Further, on the basis of end-user, the market is segmented into pharmaceutical & biopharmaceutical companies, and academic & research institutes. CRISPR being a really new technology seeks the interest of everyone from doctors to academic & research institutes. CRISPR holds a lot of hidden potentials to cure many rare and incurable diseases that are still to be discovered and is driving the academic & research institutes as an end-user segment to grow with a significant rate in the market.

Geographically, the market is segmented into four major regions; North America, Europe, Asia-Pacific and Rest of the world (RoW). Among these, North America is expected to hold a prominent position in the global CRISPR technology market. The presence of major pharma companies in the region tends to enhance the growth of the global CRISPR market. Further, the report covers the analysis of several players operating in the market. Some of the players include Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corp., Horizon Discovery Group PLC, CRISPR Therapeutics AG, and others.

Research Methodology

The market study of the CRISPR market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for CRISPR technology providers, end-user industries, existing companies, and new entrants into the market, potential investors and venture capitalists, government organizations and regulatory agencies, academic and research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, products offered by the company and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

  • 1. Global CRISPR Technology Market Research and Analysis by Application
  • 2. Global CRISPR Technology Market Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global CRISPR technology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global CRISPR technology market.
  • Insights about market determinants which are stimulating the global CRISPR technology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Thermo Fisher Scientific, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Merck KGaA
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. GenScript Biotech Corp.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Horizon Discovery Group PLC
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. CRISPR Therapeutics AG
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. CRISPR Technology Market by Application
    • 5.1.1. Biomedical Applications
    • 5.1.2. Agricultural Applications
    • 5.1.3. Industrial Applications
  • 5.2. Global CRISPR Technology Market by End-User
    • 5.2.1. Pharmaceutical and Biopharmaceutical Companies
    • 5.2.2. Academic & Research Institutes

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AstraZeneca PLC
  • 7.2. BASF SE
  • 7.3. Beam Therapeutics Inc.
  • 7.4. Bio-Rad Laboratories, Inc.
  • 7.5. Caribou Bioscience Inc.
  • 7.6. Cellectics SA
  • 7.7. Cibus, Ltd.
  • 7.8. CRISPR Therapeutics AG
  • 7.9. Danaher Corp.
  • 7.10. Editas Medicine
  • 7.11. GeneCopoeia inc.
  • 7.12. GenScript Biotech Corp.
  • 7.13. Horizon Discovery Group PLC
  • 7.14. Intellia Therapeutics Inc.
  • 7.15. Lonza Group Ltd.
  • 7.16. Merck KGaA
  • 7.17. New England Biolabs, Inc.
  • 7.18. Origene Technologies, Inc.
  • 7.19. Pairwise Plants
  • 7.20. Precision Bioscience, Inc.
  • 7.21. Sangamo Therapeutics Inc.
  • 7.22. Thermo Fisher Scientific, Inc.
  • 7.23. Transposagen Biopharmaceuticals, Inc.
  • 7.24. Tropic Biosciences UK LTD.
  • 7.25. Yield10 Bioscience, Inc.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.